Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Monalizumab

Monalizumab is a novel immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A) . Monalizumab is a humanized monoclonal antibody against NKG2A that induces IFN-γ production, thereby activating natural killer cell function. Monalizumab has antitumor activity and can be used to study neck squamous cell carcinoma (HNSCC) .

Product Specifications

CAS Number

1228763-95-8

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Chk | IFNAR

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Quercetin 3-O-glucoside-7-O-rhamnoside
300863 2 mg

Quercetin 3-O-glucoside-7-O-rhamnoside

Sign In for Pricing
View Details
Mmu-miR-3098-5p inhibitor
HY-RI02984-01 5 nmol

Mmu-miR-3098-5p inhibitor

Sign In for Pricing
View Details
Mmu-miR-3098-5p inhibitor
HY-RI02984-02 20 nmol

Mmu-miR-3098-5p inhibitor

Sign In for Pricing
View Details
Tofisopam impurity C
CS-O-32558 1 Each

Tofisopam impurity C

Sign In for Pricing
View Details
NXT1 (NTF2-like export factor 1, P15) (MaxLight 750)
MBS6231208-01 0.1 mL

NXT1 (NTF2-like export factor 1, P15) (MaxLight 750)

Sign In for Pricing
View Details
NXT1 (NTF2-like export factor 1, P15) (MaxLight 750)
MBS6231208-02 5x 0.1 mL

NXT1 (NTF2-like export factor 1, P15) (MaxLight 750)

Sign In for Pricing
View Details